 | • レポートコード：MRC2-11QY08380 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は眼科用医薬品のグローバル市場について調査・分析したレポートです。種類別（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障）市場規模、用途別（病院、クリニック、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別眼科用医薬品の競争状況、市場シェア ・世界の眼科用医薬品市場：種類別市場規模 2015年-2020年（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障） ・世界の眼科用医薬品市場：種類別市場規模予測 2021年-2026年（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障） ・世界の眼科用医薬品市場：用途別市場規模 2015年-2020年（病院、クリニック、薬局） ・世界の眼科用医薬品市場：用途別市場規模予測 2021年-2026年（病院、クリニック、薬局） ・北米の眼科用医薬品市場分析：米国、カナダ ・ヨーロッパの眼科用医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの眼科用医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の眼科用医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの眼科用医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Santen Pharmaceutical、Bausch Health、Takeda、Novartis、Genentech、Allergan、Sun Pharmaceutical Industries、Actavis Generics、Regeneron Pharmaceuticals、Pfizer、Johnson and Johnson、Bausch and Lomb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
Market Analysis and Insights: Global Ophthalmic Drugs Market
The global Ophthalmic Drugs market size is projected to reach US$ 22990 million by 2026, from US$ 22440 million in 2020, at a CAGR of 2.3%% during 2021-2026.
Global Ophthalmic Drugs Scope and Market Size
Ophthalmic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ophthalmic Drugs market is segmented into
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Segment by Application, the Ophthalmic Drugs market is segmented into
Hospital
Clinic
Pharmacy
Regional and Country-level Analysis
The Ophthalmic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ophthalmic Drugs Market Share Analysis
Ophthalmic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmic Drugs business, the date to enter into the Ophthalmic Drugs market, Ophthalmic Drugs product introduction, recent developments, etc.
The major vendors covered:
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
1 Study Coverage
1.1 Ophthalmic Drugs Product Introduction
1.2 Market Segments
1.3 Key Ophthalmic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ophthalmic Drugs Market Size Growth Rate by Type
1.4.2 Anti-allergy
1.4.3 Anti-VEGF Agents
1.4.4 Anti-inflammatory
1.4.5 Anti-glaucoma
1.5 Market by Application
1.5.1 Global Ophthalmic Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Ophthalmic Drugs Revenue 2015-2026
2.1.2 Global Ophthalmic Drugs Sales 2015-2026
2.2 Global Ophthalmic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ophthalmic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ophthalmic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Ophthalmic Drugs Competitor Landscape by Players
3.1 Ophthalmic Drugs Sales by Manufacturers
3.1.1 Ophthalmic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Ophthalmic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Ophthalmic Drugs Revenue by Manufacturers
3.2.1 Ophthalmic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Ophthalmic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ophthalmic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ophthalmic Drugs Revenue in 2019
3.2.5 Global Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ophthalmic Drugs Price by Manufacturers
3.4 Ophthalmic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ophthalmic Drugs Market Size by Type (2015-2020)
4.1.1 Global Ophthalmic Drugs Sales by Type (2015-2020)
4.1.2 Global Ophthalmic Drugs Revenue by Type (2015-2020)
4.1.3 Ophthalmic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ophthalmic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Ophthalmic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Ophthalmic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Ophthalmic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ophthalmic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Ophthalmic Drugs Market Size by Application (2015-2020)
5.1.1 Global Ophthalmic Drugs Sales by Application (2015-2020)
5.1.2 Global Ophthalmic Drugs Revenue by Application (2015-2020)
5.1.3 Ophthalmic Drugs Price by Application (2015-2020)
5.2 Ophthalmic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Ophthalmic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Ophthalmic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Ophthalmic Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ophthalmic Drugs by Country
6.1.1 North America Ophthalmic Drugs Sales by Country
6.1.2 North America Ophthalmic Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ophthalmic Drugs Market Facts & Figures by Type
6.3 North America Ophthalmic Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Ophthalmic Drugs by Country
7.1.1 Europe Ophthalmic Drugs Sales by Country
7.1.2 Europe Ophthalmic Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ophthalmic Drugs Market Facts & Figures by Type
7.3 Europe Ophthalmic Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Drugs by Region
8.1.1 Asia Pacific Ophthalmic Drugs Sales by Region
8.1.2 Asia Pacific Ophthalmic Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ophthalmic Drugs Market Facts & Figures by Type
8.3 Asia Pacific Ophthalmic Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Ophthalmic Drugs by Country
9.1.1 Latin America Ophthalmic Drugs Sales by Country
9.1.2 Latin America Ophthalmic Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ophthalmic Drugs Market Facts & Figures by Type
9.3 Central & South America Ophthalmic Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Drugs by Country
10.1.1 Middle East and Africa Ophthalmic Drugs Sales by Country
10.1.2 Middle East and Africa Ophthalmic Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ophthalmic Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Ophthalmic Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Santen Pharmaceutical
11.1.1 Santen Pharmaceutical Corporation Information
11.1.2 Santen Pharmaceutical Description and Business Overview
11.1.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santen Pharmaceutical Ophthalmic Drugs Products Offered
11.1.5 Santen Pharmaceutical Related Developments
11.2 Bausch Health
11.2.1 Bausch Health Corporation Information
11.2.2 Bausch Health Description and Business Overview
11.2.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bausch Health Ophthalmic Drugs Products Offered
11.2.5 Bausch Health Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description and Business Overview
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Ophthalmic Drugs Products Offered
11.3.5 Takeda Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Ophthalmic Drugs Products Offered
11.4.5 Novartis Related Developments
11.5 Genentech
11.5.1 Genentech Corporation Information
11.5.2 Genentech Description and Business Overview
11.5.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Genentech Ophthalmic Drugs Products Offered
11.5.5 Genentech Related Developments
11.6 Allergan
11.6.1 Allergan Corporation Information
11.6.2 Allergan Description and Business Overview
11.6.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Allergan Ophthalmic Drugs Products Offered
11.6.5 Allergan Related Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Corporation Information
11.7.2 Sun Pharmaceutical Industries Description and Business Overview
11.7.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sun Pharmaceutical Industries Ophthalmic Drugs Products Offered
11.7.5 Sun Pharmaceutical Industries Related Developments
11.8 Actavis Generics
11.8.1 Actavis Generics Corporation Information
11.8.2 Actavis Generics Description and Business Overview
11.8.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Actavis Generics Ophthalmic Drugs Products Offered
11.8.5 Actavis Generics Related Developments
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Corporation Information
11.9.2 Regeneron Pharmaceuticals Description and Business Overview
11.9.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Regeneron Pharmaceuticals Ophthalmic Drugs Products Offered
11.9.5 Regeneron Pharmaceuticals Related Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Description and Business Overview
11.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Ophthalmic Drugs Products Offered
11.10.5 Pfizer Related Developments
11.1 Santen Pharmaceutical
11.1.1 Santen Pharmaceutical Corporation Information
11.1.2 Santen Pharmaceutical Description and Business Overview
11.1.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santen Pharmaceutical Ophthalmic Drugs Products Offered
11.1.5 Santen Pharmaceutical Related Developments
11.12 Bausch and Lomb
11.12.1 Bausch and Lomb Corporation Information
11.12.2 Bausch and Lomb Description and Business Overview
11.12.3 Bausch and Lomb Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bausch and Lomb Products Offered
11.12.5 Bausch and Lomb Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ophthalmic Drugs Market Estimates and Projections by Region
12.1.1 Global Ophthalmic Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Ophthalmic Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Ophthalmic Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Ophthalmic Drugs Sales Forecast (2021-2026)
12.2.2 North America: Ophthalmic Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Ophthalmic Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Ophthalmic Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Ophthalmic Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Ophthalmic Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Ophthalmic Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ophthalmic Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ophthalmic Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ophthalmic Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ophthalmic Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Ophthalmic Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Ophthalmic Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Ophthalmic Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Ophthalmic Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ophthalmic Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ophthalmic Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ophthalmic Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ophthalmic Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ophthalmic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ophthalmic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Ophthalmic Drugs Market Segments
Table 2. Ranking of Global Top Ophthalmic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ophthalmic Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Anti-allergy
Table 5. Major Manufacturers of Anti-VEGF Agents
Table 6. Major Manufacturers of Anti-inflammatory
Table 7. Major Manufacturers of Anti-glaucoma
Table 8. Global Ophthalmic Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Ophthalmic Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Ophthalmic Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Ophthalmic Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Ophthalmic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Ophthalmic Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Ophthalmic Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Ophthalmic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Ophthalmic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Drugs as of 2019)
Table 17. Ophthalmic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Ophthalmic Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Ophthalmic Drugs Price (2015-2020) (USD/MT)
Table 20. Ophthalmic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Ophthalmic Drugs Product Type
Table 22. Date of International Manufacturers Enter into Ophthalmic Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Ophthalmic Drugs Sales by Type (2015-2020) (K MT)
Table 25. Global Ophthalmic Drugs Sales Share by Type (2015-2020)
Table 26. Global Ophthalmic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Ophthalmic Drugs Revenue Share by Type (2015-2020)
Table 28. Ophthalmic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Ophthalmic Drugs Sales by Application (2015-2020) (K MT)
Table 30. Global Ophthalmic Drugs Sales Share by Application (2015-2020)
Table 31. North America Ophthalmic Drugs Sales by Country (2015-2020) (K MT)
Table 32. North America Ophthalmic Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Ophthalmic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Ophthalmic Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Ophthalmic Drugs Sales by Type (2015-2020) (K MT)
Table 36. North America Ophthalmic Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Ophthalmic Drugs Sales by Application (2015-2020) (K MT)
Table 38. North America Ophthalmic Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Ophthalmic Drugs Sales by Country (2015-2020) (K MT)
Table 40. Europe Ophthalmic Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Ophthalmic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Ophthalmic Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Ophthalmic Drugs Sales by Type (2015-2020) (K MT)
Table 44. Europe Ophthalmic Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Ophthalmic Drugs Sales by Application (2015-2020) (K MT)
Table 46. Europe Ophthalmic Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Ophthalmic Drugs Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Ophthalmic Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Ophthalmic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Ophthalmic Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Ophthalmic Drugs Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Ophthalmic Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Ophthalmic Drugs Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Ophthalmic Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Ophthalmic Drugs Sales by Country (2015-2020) (K MT)
Table 56. Latin America Ophthalmic Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Ophthalmic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Ophthalmic Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Ophthalmic Drugs Sales by Type (2015-2020) (K MT)
Table 60. Latin America Ophthalmic Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Ophthalmic Drugs Sales by Application (2015-2020) (K MT)
Table 62. Latin America Ophthalmic Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Ophthalmic Drugs Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Ophthalmic Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Ophthalmic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Ophthalmic Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Ophthalmic Drugs Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Ophthalmic Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Ophthalmic Drugs Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Ophthalmic Drugs Sales Market Share by Application (2015-2020)
Table 71. Santen Pharmaceutical Corporation Information
Table 72. Santen Pharmaceutical Description and Major Businesses
Table 73. Santen Pharmaceutical Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Santen Pharmaceutical Product
Table 75. Santen Pharmaceutical Recent Development
Table 76. Bausch Health Corporation Information
Table 77. Bausch Health Description and Major Businesses
Table 78. Bausch Health Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Bausch Health Product
Table 80. Bausch Health Recent Development
Table 81. Takeda Corporation Information
Table 82. Takeda Description and Major Businesses
Table 83. Takeda Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Takeda Product
Table 85. Takeda Recent Development
Table 86. Novartis Corporation Information
Table 87. Novartis Description and Major Businesses
Table 88. Novartis Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Novartis Product
Table 90. Novartis Recent Development
Table 91. Genentech Corporation Information
Table 92. Genentech Description and Major Businesses
Table 93. Genentech Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Genentech Product
Table 95. Genentech Recent Development
Table 96. Allergan Corporation Information
Table 97. Allergan Description and Major Businesses
Table 98. Allergan Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Allergan Product
Table 100. Allergan Recent Development
Table 101. Sun Pharmaceutical Industries Corporation Information
Table 102. Sun Pharmaceutical Industries Description and Major Businesses
Table 103. Sun Pharmaceutical Industries Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Sun Pharmaceutical Industries Product
Table 105. Sun Pharmaceutical Industries Recent Development
Table 106. Actavis Generics Corporation Information
Table 107. Actavis Generics Description and Major Businesses
Table 108. Actavis Generics Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Actavis Generics Product
Table 110. Actavis Generics Recent Development
Table 111. Regeneron Pharmaceuticals Corporation Information
Table 112. Regeneron Pharmaceuticals Description and Major Businesses
Table 113. Regeneron Pharmaceuticals Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Regeneron Pharmaceuticals Product
Table 115. Regeneron Pharmaceuticals Recent Development
Table 116. Pfizer Corporation Information
Table 117. Pfizer Description and Major Businesses
Table 118. Pfizer Ophthalmic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Pfizer Product
Table 120. Pfizer Recent Development
Table 121. Johnson and Johnson Corporation Information
Table 122. Johnson and Johnson Description and Major Businesses
Table 123. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Johnson and Johnson Product
Table 125. Johnson and Johnson Recent Development
Table 126. Bausch and Lomb Corporation Information
Table 127. Bausch and Lomb Description and Major Businesses
Table 128. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Bausch and Lomb Product
Table 130. Bausch and Lomb Recent Development
Table 131. Global Ophthalmic Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 132. Global Ophthalmic Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Ophthalmic Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Ophthalmic Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Ophthalmic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 136. North America: Ophthalmic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Ophthalmic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 138. Europe: Ophthalmic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Ophthalmic Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 140. Asia Pacific: Ophthalmic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Ophthalmic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 142. Latin America: Ophthalmic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Ophthalmic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 144. Middle East and Africa: Ophthalmic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Ophthalmic Drugs Players
Table 149. Ophthalmic Drugs Customers List
Table 150. Ophthalmic Drugs Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmic Drugs Product Picture
Figure 2. Global Ophthalmic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-allergy Product Picture
Figure 4. Anti-VEGF Agents Product Picture
Figure 5. Anti-inflammatory Product Picture
Figure 6. Anti-glaucoma Product Picture
Figure 7. Global Ophthalmic Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Ophthalmic Drugs Report Years Considered
Figure 12. Global Ophthalmic Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Ophthalmic Drugs Sales 2015-2026 (K MT)
Figure 14. Global Ophthalmic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Ophthalmic Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Ophthalmic Drugs Sales Market Share by Region in 2019
Figure 17. Global Ophthalmic Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Ophthalmic Drugs Revenue Market Share by Region in 2019
Figure 19. Global Ophthalmic Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Ophthalmic Drugs Revenue in 2019
Figure 21. Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Ophthalmic Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Ophthalmic Drugs Sales Market Share by Type in 2019
Figure 24. Global Ophthalmic Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Ophthalmic Drugs Revenue Market Share by Type in 2019
Figure 26. Global Ophthalmic Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Ophthalmic Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Ophthalmic Drugs Sales Market Share by Application in 2019
Figure 29. Global Ophthalmic Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Ophthalmic Drugs Revenue Market Share by Application in 2019
Figure 31. North America Ophthalmic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Ophthalmic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Ophthalmic Drugs Sales Market Share by Country in 2019
Figure 34. North America Ophthalmic Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Ophthalmic Drugs Market Share by Type in 2019
Figure 40. North America Ophthalmic Drugs Market Share by Application in 2019
Figure 41. Europe Ophthalmic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Ophthalmic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Ophthalmic Drugs Sales Market Share by Country in 2019
Figure 44. Europe Ophthalmic Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Ophthalmic Drugs Market Share by Type in 2019
Figure 56. Europe Ophthalmic Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Ophthalmic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Ophthalmic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Ophthalmic Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Ophthalmic Drugs Revenue Market Share by Region in 2019
Figure 61. China Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Ophthalmic Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Ophthalmic Drugs Market Share by Application in 2019
Figure 85. Latin America Ophthalmic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Ophthalmic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Ophthalmic Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Ophthalmic Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Ophthalmic Drugs Market Share by Type in 2019
Figure 96. Latin America Ophthalmic Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Ophthalmic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Ophthalmic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Ophthalmic Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Ophthalmic Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Ophthalmic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Ophthalmic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Ophthalmic Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Ophthalmic Drugs Market Share by Application in 2019
Figure 109. North America Ophthalmic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Ophthalmic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Ophthalmic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Ophthalmic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Ophthalmic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Ophthalmic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Ophthalmic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Ophthalmic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Ophthalmic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Ophthalmic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…